HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vera Cavalcanti de Araújo Selected Research

Pleomorphic Adenoma

6/2019Comparison of p63/p40 Expression With Myoepithelial Markers in Minor Salivary Gland Tumors.
1/2019Estrogen Receptor, Progesterone Receptor, and HER-2 Expression in Recurrent Pleomorphic Adenoma.
5/2013In vitro cytokine expression in in situ-like areas of malignant neoplasia.
9/2012In vitro evaluation of the suppressor potential of conditioned medium from benign myoepithelial cells from pleomorphic adenoma in malignant cell invasion.
3/2012The increased PDGF-A, PDGF-B and FGF-2 expression in recurrence of salivary gland pleomorphic adenoma.
2/2012In vitro influence of the extracellular matrix in myoepithelial cells stimulated by malignant conditioned medium.
2/2011Increased mucin 1 expression in recurrence and malignant transformation of salivary gland pleomorphic adenoma.
8/2010Study of growth factors and receptors in carcinoma ex pleomorphic adenoma.
1/2010FGF-2, TGFbeta-1, PDGF-A and respective receptors expression in pleomorphic adenoma myoepithelial cells: an in vivo and in vitro study.
9/2008Mdm2, p53, p21 and pAKT protein pathways in benign neoplasms of the salivary gland.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vera Cavalcanti de Araújo Research Topics

Disease

17Neoplasms (Cancer)
09/2020 - 02/2004
14Pleomorphic Adenoma
06/2019 - 08/2004
7Carcinoma (Carcinomatosis)
08/2021 - 06/2006
5Carcinogenesis
09/2020 - 07/2006
4Adenoid Cystic Carcinoma (Cylindroma)
06/2019 - 06/2006
4Adenocarcinoma
06/2019 - 07/2006
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2013 - 02/2012
2Salivary Gland Neoplasms (Salivary Gland Cancer)
09/2008 - 02/2004
2Neoplasm Metastasis (Metastasis)
08/2004 - 07/2004
1Carcinoma in Situ
08/2021
1Mucoepidermoid Carcinoma
06/2019
1Odontogenic Tumors (Dental Tissue Neoplasm)
01/2019
1Retinoblastoma (Glioblastoma, Retinal)
09/2015
1Inflammation (Inflammations)
06/2015
1Osteonecrosis (Kienbock's Disease)
03/2015
1Cysts
11/2013
1Periodontitis
07/2013
1Melanoma (Melanoma, Malignant)
09/2012
1Breast Neoplasms (Breast Cancer)
09/2012
1Squamous Cell Carcinoma of Head and Neck
09/2012
1Polyps
07/2011
1Infections
07/2011
1Neoplastic Processes
08/2010
1Mucocele
09/2009
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
05/2009
1Burkitt Lymphoma (Burkitt's Lymphoma)
05/2009
1Lymphoma (Lymphomas)
05/2009
1Plasmablastic Lymphoma
05/2009
1Myoepithelioma
09/2008
1Noninfiltrating Intraductal Carcinoma (DCIS)
11/2006
1Hemorrhage
03/2005

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
12/2019 - 02/2004
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2020 - 01/2010
4VimentinIBA
06/2019 - 07/2004
4AntibodiesIBA
08/2010 - 07/2006
3Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
03/2012 - 01/2010
3Phenobarbital (Luminal)FDA Link
08/2010 - 08/2004
2Biological ProductsIBA
01/2019 - 08/2010
2CytokinesIBA
06/2015 - 05/2013
2Keratin-7 (Cytokeratin 7)IBA
11/2013 - 06/2011
2Keratin-20 (Cytokeratin 20)IBA
11/2013 - 06/2011
2Messenger RNA (mRNA)IBA
07/2013 - 02/2004
2Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
03/2012 - 08/2010
2platelet-derived growth factor AIBA
03/2012 - 01/2010
2Fibronectins (Fibronectin)IBA
02/2012 - 07/2011
2Transforming Growth Factors (Transforming Growth Factor)IBA
08/2010 - 01/2010
2SERPIN-B5 (maspin)IBA
11/2006 - 08/2004
1phytobacteriomycin (PBM)IBA
08/2021
1Matrix Metalloproteinases (MMPs)IBA
09/2020
1ParaffinIBA
06/2019
1Formaldehyde (Formol)FDA Link
06/2019
1Estrogen ReceptorsIBA
01/2019
1Progesterone Receptors (Progesterone Receptor)IBA
01/2019
1PercollIBA
10/2017
1Cyclin D1IBA
09/2015
1Cell Cycle ProteinsIBA
09/2015
1Diphosphonates (Bisphosphonates)IBA
03/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2015
1Endothelial Growth FactorsIBA
01/2015
1Thyroid Nuclear Factor 1IBA
11/2013
1Interleukin-6 (Interleukin 6)IBA
05/2013
1Interleukin-10 (Interleukin 10)IBA
05/2013
1Interleukin-4 (Interleukin 4)IBA
05/2013
1matrigelIBA
09/2012
1Conditioned Culture MediaIBA
09/2012
1Platelet-Derived Growth FactorIBA
03/2012
1Collagen Type I (Type I Collagen)IBA
02/2012
1Extracellular Matrix ProteinsIBA
02/2012
1Secretory Immunoglobulin A (SIgA)IBA
07/2011
1CollagenIBA
07/2011
1TenascinIBA
07/2011
1Mucin-1 (CA 15-3 Antigen)IBA
02/2011
1ErbB Receptors (EGF Receptor)IBA
08/2010
1Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
08/2010
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
08/2010
1Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
08/2010
1Somatomedin Receptors (Somatomedin Receptor)IBA
08/2010
1S100 Proteins (S 100 Protein)IBA
05/2009
1Calmodulin-Binding Proteins (Caldesmon)IBA
05/2009
1Proto-Oncogene Proteins c-mdm2IBA
09/2008
1Laminin (Merosin)IBA
11/2006
1CalponinsIBA
11/2006
1Cadherins (E-Cadherin)IBA
07/2006
1beta CateninIBA
07/2006
1Hemostatics (Antihemorrhagics)IBA
03/2005
1DesminIBA
07/2004
1Proliferating Cell Nuclear Antigen (PCNA)IBA
02/2004

Therapy/Procedure

1Low-Level Light Therapy (LLLT)
08/2021
1Therapeutics
01/2019
1Debridement
03/2015
1Drug Therapy (Chemotherapy)
06/2011
1Oral Surgery (Maxillofacial Surgery)
09/2009